Latest News about PFE
Recent news which mentions PFE
Pfizer Issues FY24 Forecast, Joins Target Hospitality, Southwest Airlines And Other Big Stocks Moving Lower On Wednesday
December 13, 2023
From Benzinga
2 Big-Name Stocks Are Falling Wednesday -- Here's Why
December 13, 2023
From Motley Fool
Pfizer’s stock down 8% as 2024 profit and revenue guidance falls short of expectations
December 13, 2023
From MarketWatch
Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades'
December 13, 2023
From Benzinga
Why Is US Pharma Giant Pfizer Stock Trading Lower Today?
December 13, 2023
From Benzinga
Seeking Passive Income? 7 Dividend Stocks You Don’t Want to Miss.
December 13, 2023
From InvestorPlace
3 Dirt-Cheap Stocks to Buy Hand Over Fist Before the End of the Year
December 13, 2023
From Motley Fool
What's Going On With Moderna Stock Today?
December 12, 2023
From Benzinga
From Benzinga
From Benzinga
Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?
December 12, 2023
From Motley Fool
3 Dirt Cheap Stocks That Make Terrific Buys Before the End of the Year
December 12, 2023
From Motley Fool
From Benzinga
3 Dividend Stocks Trading at 52-Week Lows
December 09, 2023
From Motley Fool
3 Blue-Chip Stocks Set to Make a Comeback in 2024
December 08, 2023
From InvestorPlace
Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them'
December 08, 2023
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 08, 2023
From Benzinga
Pfizer's Latest Ozempic Competitor Just Flopped (Again). Is the Stock Still a Buy?
December 08, 2023
Tickers
PFE
From Motley Fool
7 Tech Stocks to Light Up Your Portfolio This Holiday Season
December 08, 2023
From InvestorPlace
7 F-Rated Stocks to Sell in December
December 08, 2023
From InvestorPlace
Vaccine Player Vaxcyte Can Potentially Disrupt Pfizer's 20-Plus-Year Near Monopoly, Says Analyst
December 07, 2023
From Benzinga
From MarketWatch
From MarketWatch
Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy
December 07, 2023
From InvestorPlace
From Motley Fool
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
December 06, 2023
From Benzinga
2024's Potential Stock Surprises: Goldman Sachs Unveils S&P 500 Laggards For Major Gains
December 06, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.